Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Decker Robert J	2. Date of Event Requiring Statement (MM/DD/YYYY) 12/27/2019	3. Issuer Name and Ticker or Trading Symbol JOHNSON & JOHNSON [JNJ]
(Last)        (First)        (Middle) ONE JOHNSON & JOHNSON PLAZA	4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                          _____ 10% Owner ___X___ Officer (give title below)        _____ Other (specify below) Controller, CAO /
(Street) NEW BRUNSWICK, NJ 08933       (City)              (State)              (Zip)	5. If Amendment, Date Original Filed(MM/DD/YYYY)	6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	12447.0000	D
Common Stock	524.0000 (1)	I	By 401k
Common Stock	134.0000 (2)	I	By ESOP

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options (Right to Buy) (3)	1/17/2016	1/13/2023	Common Stock	18462.0000	$72.5400	D
Employee Stock Options (Right to Buy) (3)	2/11/2017	2/9/2024	Common Stock	16928.0000	$90.4400	D
Employee Stock Options (Right to Buy) (3)	2/10/2018	2/9/2025	Common Stock	5635.0000	$100.0600	D
Employee Stock Options (Right to Buy) (3)	2/9/2019	2/8/2026	Common Stock	6999.0000	$101.8700	D
Employee Stock Options (Right to Buy) (3)	2/13/2020	2/13/2027	Common Stock	4075.0000	$115.6700	D
Employee Stock Options (Right to Buy) (3)	2/12/2021	2/11/2028	Common Stock	3107.0000	$129.5100	D
Employee Stock Options (Right to Buy) (3)	2/11/2022	2/11/2029	Common Stock	4212.0000	$131.9400	D
Restricted Share Units (4)	2/11/2022	(4)	Common Stock	866.0000	(4)	D
Restricted Share Units (4)	2/12/2021	(4)	Common Stock	655.0000	(4)	D
Restricted Share Units (4)	2/13/2020	(4)	Common Stock	720.0000	(4)	D

Explanation of Responses:
(1)	Shares held in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (12/31/2019).
(2)	Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (12/31/2019).
(3)	Vested and exercisable on the third anniversary of the date of the grant.
(4)	Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant.

Remarks: deckerpoa1.txt

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Decker Robert J ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK, NJ 08933			Controller, CAO

Signatures
Linda E. King, as attorney-in-fact for Robert J. Decker		1/6/2020
**Signature of Reporting Person		Date